Short-Term Use of Upadacitinib in Combination with Biologic Therapy for Inducing Clinical Remission in Patients with Active Inflammatory Bowel Disease.
INFLAMMATORY BOWEL DISEASES（2024）
关键词
upadacitinib,JAK inhibitor,inflammatory bowel disease,biologic therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要